Literature DB >> 22014252

Evaluation of a substance use disorder curriculum for internal medicine residents.

Melissa R Stein1, Julia H Arnsten, Sharon J Parish, Hillary V Kunins.   

Abstract

Teaching about diagnosis, treatment, and sequelae of substance use disorders (SUDs) is insufficient in most Internal Medicine residency programs. To address this, the authors developed, implemented, and evaluated a novel and comprehensive SUD curriculum for first year residents (interns) in Internal Medicine, which anchors the ensuing 3-year longitudinal SUD curriculum. This intern curriculum includes didactic and experiential elements and allows skills practice. Topics include local epidemiology of substance abuse, neurobiology of SUDs, and screening, treatment, and referral. The entire curriculum is delivered over 7 hours during a month-long ambulatory rotation. Among 58 interns who have completed a pre-post evaluation of the curriculum, the majority reported an increased sense of responsibility for and confidence in treating patients with SUDs.

Entities:  

Mesh:

Year:  2011        PMID: 22014252      PMCID: PMC4028621          DOI: 10.1080/08897077.2011.598408

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  7 in total

1.  A national survey of training in substance use disorders in residency programs.

Authors:  J H Isaacson; M Fleming; M Kraus; R Kahn; M Mundt
Journal:  J Stud Alcohol       Date:  2000-11

Review 2.  Medical education in substance-related disorders: components and outcome.

Authors:  N el-Guebaly; J Toews; J Lockyer; S Armstrong; D Hodgins
Journal:  Addiction       Date:  2000-06       Impact factor: 6.526

3.  Integrating addiction medicine into graduate medical education in primary care: the time has come.

Authors:  Patrick G O'Connor; Julie G Nyquist; A Thomas McLellan
Journal:  Ann Intern Med       Date:  2011-01-04       Impact factor: 25.391

Review 4.  The physician's role in caring for patients with substance use disorders: implications for medical education and training.

Authors:  David A Fiellin; Richard Butler; Gail D'Onofrio; Richard L Brown; Patrick G O'Connor
Journal:  Subst Abus       Date:  2002-09       Impact factor: 3.716

5.  Knowledge, attitudes, and reported practices of medical students and house staff regarding the diagnosis and treatment of alcoholism.

Authors:  G Geller; D M Levine; J A Mamon; R D Moore; L R Bone; E J Stokes
Journal:  JAMA       Date:  1989-06-02       Impact factor: 56.272

6.  Who teaches residents about the prevention and treatment of substance use disorders? A national survey.

Authors:  M F Fleming; L B Manwell; M Kraus; J H Isaacson; R Kahn; E A Stauffacher
Journal:  J Fam Pract       Date:  1999-09       Impact factor: 0.493

7.  Internal medicine residency training for unhealthy alcohol and other drug use: recommendations for curriculum design.

Authors:  Angela H Jackson; Daniel P Alford; Catherine E Dubé; Richard Saitz
Journal:  BMC Med Educ       Date:  2010-03-15       Impact factor: 2.463

  7 in total
  4 in total

1.  Teaching and assessing residents' skills in managing heroin addiction with objective structured clinical examinations (OSCEs).

Authors:  Sharon J Parish; Melissa R Stein; Steven R Hahn; Uri Goldberg; Julia H Arnsten
Journal:  Subst Abus       Date:  2013       Impact factor: 3.716

2.  A buprenorphine education and training program for primary care residents: implementation and evaluation.

Authors:  Hillary V Kunins; Nancy L Sohler; Angela Giovanniello; Devin Thompson; Chinazo O Cunningham
Journal:  Subst Abus       Date:  2013       Impact factor: 3.716

3.  Bridging the Gap: Dual Fellowship Training in Addiction Medicine and Digestive Diseases.

Authors:  Lamia Y Haque; David A Fiellin
Journal:  Dig Dis Sci       Date:  2022-04-16       Impact factor: 3.487

4.  Experiences and opinions of health professional students participating in an opioid use disorder educational event.

Authors:  Erin L Winstanley; Gina M Baugh; Mark Garofoli; Andrew J Muzyk
Journal:  Ment Health Clin       Date:  2020-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.